What We're Reading: Page 183
Industry reads hand-picked by our editors
Sep 08, 2020
-
MarketWatch
AstraZeneca vaccine ‘most likely’ to roll out in the U.K. early next year
-
Bloomberg
Sanofi Plans Ingredients Unit IPO Within Months, Bogillot Says
-
Endpoints News
Grifols makes a $146M bet on a Stanford play in a controversial anti-aging field
-
Pittsburgh Business Times
Mylan to acquire European drug portfolio
Sep 04, 2020
Sep 03, 2020
Sep 02, 2020
-
The Wall Street Journal
‘Russian Roulette’: Inside Putin’s Race to Develop a Covid-19 Vaccine Before the West
-
Bloomberg
Trump’s Claim Drug Companies Are Negotiating Disputed by Lobby
-
Los Angeles Times
California may be first state to develop its own generic drugs
-
POLITICO
FDA shake-up continues as another comms official removed from top role
Sep 01, 2020
Aug 31, 2020
-
The Palm Beach Post
COVID vaccine trial in county paused due to 'political pressure,' doctor says
-
The Financial Times
US government’s Darpa probes Moderna’s vaccine patents
-
The Washington Post
Inside Trump’s pressure campaign on federal scientists over a covid-19 treatment
-
Biocentury
Plasma authorization forces rethink of COVID-19 antibody trials
Previous
